Fair Value (Details) - Diagnosys - USD ($) |
Oct. 04, 2019 |
Apr. 02, 2022 |
Dec. 31, 2021 |
|---|---|---|---|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | |||
| Cash purchase price | $ 7,000,000 | ||
| Financial liabilities carried at fair value | 2,500,000 | $ 0 | $ 0 |
| Potential additional earn-out | $ 13,000,000 | ||
| Achievement period (in years) | 3 years | ||
| Earn-out achievement benchmark | $ 72,000,000 |
| X | ||||||||||
- Definition Business Combination, Contingent Consideration, Achievement Period No definition available.
|
| X | ||||||||||
- Definition Business Combination, Contingent Consideration Arrangements, Basis For Amount, Value No definition available.
|
| X | ||||||||||
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|